RGEN: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Revenue	540,343	-
Cost of goods sold	257,929	-
Research and development	41,057	-
Sales and marketing	77,495	-
General and administrative	126,563	-
Total costs and operating expenses	503,044	-
Other income, net	5,971	-
Income tax provision (benefit)	7,663	-
Net income	35,607	20,696
Depreciation and amortization	58,794	38,785
Amortization of debt discount and issuance costs	12,360	-
Inventory step-up amortization	1,069	-
Stock-based compensation	24,621	15,648
Deferred income taxes, net	-5,784	-2,569
Loss on disposal of fixed assets	-	-3,382
Change in fair value of contingent consideration	-12,087	-7,939
Net unrealized foreign exchange gain	12,443	12,253
Unrealized loss on derivative contracts	-	-8,709
Operating lease right of use asset amortization	13,570	-
Other adjustments and non-cash items	-2,532	-353
Accounts receivable	7,302	15,158
Inventories	5,346	824
Prepaid expenses and other current assets	5,494	176
Other noncurrent assets	1,727	1,547
Accounts payable	-5,083	-8,277
Accrued liabilities	9,629	-2,995
Amortization of debt discount and issuance costs	-	8,158
Operating lease liabilities	-12,096	-9,804
Operating lease right of use asset amortization	-	-9,169
Noncurrent liabilities	893	256
Total cash provided by operating activities	91,713	43,614
Acquisitions, net of cash acquired	69,954	69,954
Additions to capitalized software costs	2,055	1,371
Purchases of property, plant and equipment	15,366	10,664
Sale of property, plant and equipment	42	42
Other investing activities	2,397	-
Total cash used in investing activities	-89,730	-81,947
Proceeds from exercise of stock options	2,142	1,464
Other financing activities	-	0
Payment of tax withholding obligation on vesting of restricted stock	7,994	7,170
Repayment of convertible senior notes	0	-
Payment of earnout consideration	9,548	9,455
Total cash used in financing activities	-15,400	-15,161
Effect of exchange rate changes on cash and cash equivalents	4,809	4,994
Net (decrease) increase in cash and cash equivalents	-8,608	-48,500
Cash and cash equivalents at beginning of period	757,355	-
Cash and cash equivalents at end of period	748,747	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

RGEN: the cashflow